Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Conference call with live audio webcast today, Thursday, September 13th at 8:30am EDT FORT LEE, N.J., Sept. 13, 2018 (GLOBE NEWSWIRE) -- Immune Pharmaceuticals, Inc. (OTCQB: IMNP) (“Immune” or the...
-
Company to provide corporate update during conference call with live audio webcast on Thursday, September 13th at 8:30am EDT FORT LEE, N.J., Sept. 11, 2018 (GLOBE NEWSWIRE) -- Immune...
-
FORT LEE, N.J., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Immune Pharmaceuticals, Inc. (OTCQB: IMNP) (“Immune” or the “Company”), a biopharmaceutical company developing novel therapeutic agents for the...
-
ENGLEWOOD CLIFFS, N.J., Aug. 20, 2018 (GLOBE NEWSWIRE) -- Immune Pharmaceuticals, Inc. (OTCQB: IMNP) (“Immune” or the “Company”), a biopharmaceutical company developing novel therapeutic agents for...
-
- Special Meeting of Stockholders scheduled for August 22, 2018 postponed - - Company plans to appeal Nasdaq delisting determination - ENGLEWOOD CLIFFS, N.J., Aug. 02, 2018 (GLOBE NEWSWIRE) --...
-
ENGLEWOOD CLIFFS, N.J., July 30, 2018 (GLOBE NEWSWIRE) -- Immune Pharmaceuticals, Inc. (OTCQB: IMNP) (“Immune” or the “Company”), a biopharmaceutical company developing novel therapeutic agents for...
-
ENGLEWOOD CLIFFS, N.J., July 26, 2018 (GLOBE NEWSWIRE) -- Immune Pharmaceuticals, Inc. (Nasdaq:IMNP) (“Immune” or the “Company”), a biopharmaceutical company developing novel therapeutic agents for...
-
– Immune to hold Special Meeting of Stockholders Wednesday, August 22, 2018 – – Company encourages stockholders to vote in favor of the Board of Director’s suggested proposals – ENGLEWOOD CLIFFS,...
-
SHANGHAI, China and ENGLEWOOD CLIFFS, N.J., July 09, 2018 (GLOBE NEWSWIRE) -- WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering end-to-end...
-
Company to Request Hearing ENGLEWOOD CLIFFS, N.J., June 08, 2018 (GLOBE NEWSWIRE) -- Immune Pharmaceuticals, Inc. (Nasdaq:IMNP) (“Immune” or the “Company”), a biopharmaceutical company developing...